concept

LOCUS COERULEUS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LOCUS COERULEUS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

172Connections

2Hypotheses

0Analyses

50Outgoing

50Incoming

8Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LOCUS COERULEUS
Key Genes/Proteins	ALPHA-SYNUCLEIN, AMYLOID, APOE4, APP, AXL, BDNF
Related Diseases	AGING, ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, APOPTOSIS

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

locus-coeruleus

brain_region · 3396 words

→

Pathway Diagram

graph TD
    LOCUS_COERULEUS["LOCUS COERULEUS"]
    LOCUS_COERULEUS -->|"activates"| Norepinephrine["Norepinephrine"]
    LOCUS_COERULEUS -->|"interacts"| dorsolateral_septum["dorsolateral septum"]
    LOCUS_COERULEUS -->|"regulates"| stress["stress"]
    LOCUS_COERULEUS -->|"causes"| MICROGLIA["MICROGLIA"]
    LOCUS_COERULEUS -->|"regulates"| NEURONS["NEURONS"]
    LOCUS_COERULEUS -->|"promotes"| NEURON["NEURON"]
    CA1["CA1"] -->|"exacerbates"| LOCUS_COERULEUS
    HIPPOCAMPUS["HIPPOCAMPUS"] -->|"exacerbates"| LOCUS_COERULEUS
    DEPRESSION["DEPRESSION"] -->|"contributes to"| LOCUS_COERULEUS
    ALZHEIMER["ALZHEIMER"] -->|"regulates"| LOCUS_COERULEUS
    ALZHEIMER_S["ALZHEIMER'S"] -->|"regulates"| LOCUS_COERULEUS
    BDNF["BDNF"] -->|"regulates"| LOCUS_COERULEUS
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"regulates"| LOCUS_COERULEUS

Outgoing (73)

Target	Relation	Type	Str
Alzheimer's Disease	involved_in	disease	0.95
Cognitive Decline	risk_factor_for	phenotype	0.85
Stress Response	mediates	process	0.80
Sleep Regulation	mediates	process	0.80
depression	associated_with	disease	0.70
dorsolateral septum	interacts_with	brain_region	0.70
stress	regulates	process	0.70
Norepinephrine	implicated_in	entity	0.70
Norepinephrine	inhibits	entity	0.70
Norepinephrine	activates	entity	0.70
DOPAMINE	associated_with	phenotype	0.65
DOPAMINE	causes	phenotype	0.65
TAU	associated_with	protein	0.65
ALZHEIMER'S DISEASE	interacts_with	disease	0.65
ALZHEIMER'S DISEASE	produces	disease	0.65
MICROGLIA	inhibits	cell_type	0.65
MICROGLIA	causes	cell_type	0.65
ALZHEIMER'S DISEASE	causes	disease	0.65
TAU	phosphorylates	protein	0.65
EXCITOTOXICITY	causes	phenotype	0.65
ALZHEIMER'S DISEASE	activates	disease	0.65
ALZHEIMER'S DISEASE	treats	disease	0.65
AMYLOID	activates	protein	0.65
ALZHEIMER'S DISEASE	protects_against	disease	0.65
NEURONS	associated_with	cell_type	0.60
NEURON	associated_with	cell_type	0.60
NEURONS	regulates	cell_type	0.60
MITOCHONDRIAL DYSFUNCTION	implicated_in	phenotype	0.55
TH	associated_with	gene	0.55
SCHIZOPHRENIA	co_discussed	entity	0.50
NEUROINFLAMMATION	co_discussed	entity	0.50
MICROGLIA	co_discussed	entity	0.50
TAU	co_discussed	entity	0.50
SEROTONERGIC	co_discussed	entity	0.50
SUBSTANTIA NIGRA	co_discussed	entity	0.50
SYNAPTIC PLASTICITY	co_discussed	entity	0.50
STING	co_discussed	entity	0.50
OXIDATIVE STRESS	co_discussed	entity	0.50
MITOCHONDRIA	co_discussed	entity	0.50
MITOCHONDRIAL DYSFUNCTION	co_discussed	entity	0.50
PSP	co_discussed	entity	0.50
SLEEP	co_discussed	entity	0.50
PREFRONTAL	co_discussed	entity	0.50
LRP1	associated_with	gene	0.50
BDNF	associated_with	gene	0.45
LEWY BODIES	associated_with	phenotype	0.45
AGING	associated_with	phenotype	0.45
NOREPINEPHRINE	associated_with	phenotype	0.45
APP	associated_with	gene	0.45
APOPTOSIS	associated_with	phenotype	0.45

Incoming (99)

Source	Relation	Type	Str
Hyperphosphorylated Tau	biomarker_for	biomarker	0.90
norepinephrine	active_in	neurotransmitter	0.80
Parkinson's disease	affects	disease	0.70
neurodegeneration	affects	disease	0.70
APOPTOSIS	causes	phenotype	0.65
CA1	exacerbates	brain_region	0.65
HIPPOCAMPUS	exacerbates	brain_region	0.65
TAU	activates	protein	0.65
axon	enriched_in	organelle	0.60
dementia with Lewy bodies	affects	disease	0.60
ALZHEIMER'S	regulates	disease	0.60
Alzheimer's disease	affects	disease	0.60
BDNF	expressed_in	gene	0.60
depression	affects	disease	0.60
neuroinflammation	affects	disease	0.60
ALZHEIMER	regulates	disease	0.60
DEPRESSION	contributes_to	disease	0.60
BDNF	regulates	gene	0.58
ALZHEIMER'S DISEASE	regulates	disease	0.58
BDNF	expressed_in	gene	0.55
AND	expressed_in	gene	0.55
NLRP3	expressed_in	gene	0.55
TAU	expressed_in	gene	0.55
HCRT	expressed_in	gene	0.55
DEPRESSION	expressed_in	gene	0.55
OXIDATIVE STRESS	expressed_in	gene	0.55
AGING	expressed_in	gene	0.55
NEURODEGENERATION	expressed_in	gene	0.55
ANXIETY	expressed_in	gene	0.55
NEUROINFLAMMATION	expressed_in	gene	0.55
CYTOKINES	expressed_in	gene	0.55
INFLAMMATION	expressed_in	gene	0.55
DEMENTIA	expressed_in	gene	0.55
PARKINSON	expressed_in	gene	0.55
PARKINSON'S DISEASE	expressed_in	gene	0.55
MICROGLIA	expressed_in	gene	0.55
GENES	expressed_in	gene	0.55
ALZHEIMER	expressed_in	gene	0.55
ALZHEIMER'S DISEASE	expressed_in	gene	0.55
PROINFLAMMATORY CYTOKINES	expressed_in	gene	0.55
NEURODEGENERATIVE DISORDERS	expressed_in	gene	0.55
SST	expressed_in	gene	0.55
Dementia	associated_with	disease	0.50
GLYMPHATIC	co_discussed	entity	0.50
APOPTOSIS	co_discussed	entity	0.50
Lewy Body	associated_with	disease	0.50
Parkinson	associated_with	disease	0.50
FRONTOTEMPORAL	co_discussed	entity	0.50
Alzheimer	associated_with	disease	0.50
ALZHEIMER'S	co_discussed	entity	0.50

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Locus Coeruleus-Hippocampal Circuit Protection	0.653	neuroscience	Circuit-level neural dynamics in neurode
Locus coeruleus degeneration gates whether cholinergic dysfu	0.620	neurodegeneration	What determines the temporal sequence of

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (8)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort	clinical	Alzheimer's disease	0.950	Chilean older adults (n=318) w	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	primary rodent neuronal cultur	proposed	N/A
Differential GWAS of schizophrenia vs PTSD	exploratory	schizophrenia, post-traumatic	0.900	human patients - European ance	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	primary rodent neuronal cultur	proposed	N/A
Creation and validation of 3xAD-ChAT-Cre mouse model	validation	Alzheimer's disease	0.900	3xAD-ChAT-Cre transgenic mice	proposed	N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus	exploratory	schizophrenia, post-traumatic	0.850	human brain tissue samples fro	proposed	N/A
Microtubule domain analysis in adult axons	exploratory		0.800	adult rodent axons	proposed	N/A
Tau depletion effects on microtubule domains in adult axons	exploratory		0.800	adult rodent neurons	proposed	N/A

Related Papers (14)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks. [PMID:41714746]	["Petersen Kellen K", "Mil\u00e0-Alom\u0	Nature medicine	2026
A minimally invasive dried blood spot biomarker test for the detection of Alzhei [PMID:41491101]	Huber H, Montoliu-Gaya L, Brum WS, Vávra	Nat Med	2026
Experimental and translational models of Alzheimer's disease: From neurodegenera [PMID:41619411]	Khan N, De S, Boddu S, Pravala N	J Prev Alzheimers Dis	2026
TP53/TAU axis regulates microtubule bundling to control alveolar stem cell-media [PMID:41642658]	Konishi S, Enkhbayar K, Liu S, Miyashita	J Clin Invest	2026
Spontaneous tauopathy with parkinsonism in an aged cynomolgus macaque. [PMID:41695270]	Takahashi M, Taniguchi D, Funayama M, Ci	Front Aging Neurosci	2026
Differential genome-wide association analysis of schizophrenia and post-traumati [PMID:41767305]	Cheng ZS	Front Genet	2026
Genetic architecture of plasma pTau217 and related biomarkers in Alzheimer's dis [PMID:41804841]	Kim JP, Song M, Cho M, Lee H, Jung SH et	Alzheimers Dement	2026
Shared genetic architecture between Parkinson's disease and self-reported sleep- [PMID:41822813]	Aguilar-Roldán A, Ogonowski NS, Rentería	Sleep Adv	2026
Astroglial and Neuronal Injury Markers (GFAP, UCHL-1, NfL, Tau, S100B) as Diagno [PMID:41828591]	Ogłodek EA, Bar M	Int J Mol Sci	2026
CRISPR-Cas9 and next-generation gene editing strategies for therapeutic interven [PMID:41931258]	Khan MS, Zafar I, Jamal A, Bahwerth FS,	Acta Neurol Belg	2026
Alzheimer's disease basics: we all should know. [PMID:40639927]	Das S	Neurological research	2026
Progressive Supranuclear Palsy-A Global Review. [PMID:40898879]	Kukkle PL, Neupane R, Pantelyat A, Wills	Movement disorders clinical pr	2026
NAD+ restores proteostasis through splicing-dependent autophagy. [PMID:41313318]	Ai R, Fang EF	Autophagy	2026
Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268]	["Srivastav Jyotsna", "Sharma Sachin"]	Frontiers in medicine	2025

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning LOCUS COERULEUS in their description or question text

No additional research found